Table:
begin	end	state
1	11	cytoplasmic
12	30	transmembrane
31	37	non-cytoplasmic
38	60	transmembrane
61	83	cytoplasmic
84	102	transmembrane
103	125	non-cytoplasmic
126	146	transmembrane
147	155	cytoplasmic
156	179	transmembrane
180	196	non-cytoplasmic
197	218	transmembrane
219	238	cytoplasmic
239	261	transmembrane
262	291	non-cytoplasmic
292	312	transmembrane
313	343	cytoplasmic
344	363	transmembrane
364	382	non-cytoplasmic
383	400	transmembrane
401	413	cytoplasmic
414	435	transmembrane
436	446	non-cytoplasmic
447	470	transmembrane
471	476	cytoplasmic

Input:
>15023 FitnessBrowser__Keio:15023
MAGNVQEKQLRWYNIALMSFITVWGFGNVVNNYANQGLVVVFSWVFIFALYFTPYALIVG
QLGSTFKDGKGGVSTWIKHTMGPGLAYLAAWTYWVVHIPYLAQKPQAILIALGWAMKGDG
SLIKEYSVVALQGLTLVLFIFFMWVASRGMKSLKIVGSVAGIAMFVMSLLYVAMAVTAPA
ITEVHIATTNITWETFIPHIDFTYITTISMLVFAVGGAEKISPYVNQTRNPGKEFPKGML
CLAVMVAVCAILGSLAMGMMFDSRNIPDDLMTNGQYYAFQKLGEYYNMGNTLMVIYAIAN
TLGQVAALVFSIDAPLKVLLGDADSKYIPASLCRTNASGTPVNGYFLTLVLVAILIMLPT
LGIGDMNNLYKWLLNLNSVVMPLRYLWVFVAFIAVVRLAQKYKPEYVFIRNKPLAMTVGI
WCFAFTAFACLTGIFPKMEAFTAEWTFQLALNVATPFVLVGLGLIFPLLARKANSK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server